A recent report analyzed the relationship between the α-2,6 sialyltransferases ST6GAL1, ST6GAL2, and ST6GALNAC1 and tumor-infiltrating lymphocyte (TIL) in different breast cancer molecular subgroups. Here, ST6GAL2 is linked to breast carcinoma.